安科生物(300009)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300009 安科生物

交易中 08-14 14:52:09

{"stockData":{"symbol":"300009","market":"SZ","secType":"STK","nameCN":"安科生物","latestPrice":11.63,"timestamp":1755154329000,"preClose":11.89,"halted":0,"volume":84391954,"delay":0,"changeRate":-0.0219,"floatShares":1222000000,"shares":1673000000,"eps":0.4175,"marketStatus":"交易中","change":-0.26,"latestTime":"08-14 14:52:09","open":11.98,"high":12.08,"low":11.63,"amount":1001000000,"amplitude":0.0378,"askPrice":11.64,"askSize":1142,"bidPrice":11.63,"bidSize":147,"shortable":0,"etf":0,"ttmEps":0.4175,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1755154800000},"marketStatusCode":2,"adr":0,"adjPreClose":11.89,"symbolType":"stock","openAndCloseTimeList":[[1755135000000,1755142200000],[1755147600000,1755154800000]],"highLimit":13.08,"lowLimit":10.7,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1672521258,"isCdr":false,"pbRate":4.87,"roa":"--","peRate":27.856287,"roe":"5.1%","epsLYR":0.42,"committee":0.507315,"marketValue":19451000000,"turnoverRate":0.0691,"status":1,"floatMarketCap":14208000000},"requestUrl":"/m/hq/s/300009","defaultTab":"news","newsList":[{"id":"2558639558","title":"单抗概念盘中拉升，安科生物涨9.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558639558","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558639558?lang=zh_cn&edition=full","pubTime":"2025-08-11 13:12","pubTimestamp":1754889170,"startTime":"0","endTime":"0","summary":"08月11日，单抗概念盘中拉升，截至13点12分，单抗概念整体指数上涨1.01%，报2710.550点。从个股上来看，该概念的成分股中，安科生物涨9.69%，百奥泰、泽璟制药-U、百济神州-U涨幅居前。从资金上来看，截止发稿，单抗概念概念主力净流入为-3.14亿，其中华东医药受到资金热捧，主力净流入3116.51万；拉长时间线来看，该板块近20日主力资金净流入-67.68亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081113125094dc0f62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081113125094dc0f62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","300009","688177","BK0060","688235","BK0239","BK0042","688266"],"gpt_icon":0},{"id":"2558263941","title":"肿瘤治疗概念盘中拉升，安科生物涨11.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558263941","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558263941?lang=zh_cn&edition=full","pubTime":"2025-08-11 13:01","pubTimestamp":1754888485,"startTime":"0","endTime":"0","summary":"08月11日，肿瘤治疗概念盘中拉升，截至13点01分，肿瘤治疗概念整体指数上涨1.00%，报1745.730点。从个股上来看，该概念的成分股中，安科生物涨11.22%，振东制药、键凯科技等3只股涨幅超过5%。从资金上来看，截止发稿，肿瘤治疗概念主力净流入为-5.30亿，其中海辰药业受到资金热捧，主力净流入5907.77万；拉长时间线来看，该板块近20日主力资金净流入-134.71亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811130125a6dee6a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811130125a6dee6a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","300009","688356","BK0229","BK0060","BK0239","BK0042"],"gpt_icon":0},{"id":"2558635958","title":"新冠抗原检测概念盘中拉升，安科生物涨11.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558635958","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558635958?lang=zh_cn&edition=full","pubTime":"2025-08-11 11:29","pubTimestamp":1754882968,"startTime":"0","endTime":"0","summary":"08月11日，新冠抗原检测概念盘中拉升，截至11点29分，新冠抗原检测概念整体指数上涨1.00%，报1078.450点。从个股上来看，该概念的成分股中，安科生物涨11.13%，塞力医疗、达威股份2只股涨幅超过5%。从资金上来看，截止发稿，新冠抗原检测概念主力净流入为-2.67亿，其中塞力医疗受到资金热捧，主力净流入1.50亿；拉长时间线来看，该板块近20日主力资金净流入-55.85亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081111292894dbe99e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081111292894dbe99e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0042","BK0239","BK0070","300009","BK0250","BK0060","603716"],"gpt_icon":0},{"id":"2558863811","title":"体外诊断概念盘中拉升，安科生物涨10.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558863811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558863811?lang=zh_cn&edition=full","pubTime":"2025-08-11 10:07","pubTimestamp":1754878043,"startTime":"0","endTime":"0","summary":"08月11日，体外诊断概念盘中拉升，截至10点07分，体外诊断概念整体指数上涨1.01%，报1236.300点。从个股上来看，该概念的成分股中，安科生物涨10.95%，塞力医疗涨幅超过5%。从资金上来看，截止发稿，体外诊断概念概念主力净流入为1561.83万，其中塞力医疗受到资金热捧，主力净流入1.66亿；拉长时间线来看，该板块近20日主力资金净流入-33.95亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811100723973fe9fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811100723973fe9fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0060","BK0250","300009","BK0239","603716","BK0042"],"gpt_icon":0},{"id":"2558063815","title":"细胞免疫治疗概念盘中拉升，安科生物涨8.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558063815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558063815?lang=zh_cn&edition=full","pubTime":"2025-08-11 10:02","pubTimestamp":1754877764,"startTime":"0","endTime":"0","summary":"08月11日，细胞免疫治疗概念盘中拉升，截至10点02分，细胞免疫治疗概念整体指数上涨1.01%，报1041.750点。从个股上来看，该概念的成分股中，安科生物涨8.53%，百普赛斯、济民健康、*ST生物涨幅居前。从资金上来看，截止发稿，细胞免疫治疗概念主力净流入为-2.48亿，其中佐力药业受到资金热捧，主力净流入1614.73万；拉长时间线来看，该板块近20日主力资金净流入-79.42亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811100244a480f288&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811100244a480f288&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","BK0042","300009","BK0239","BK0060","BK0070","603222","BK0201"],"gpt_icon":0},{"id":"2557954433","title":"安科生物(300009.SZ)：PA3-17注射液纳入拟突破性治疗品种","url":"https://stock-news.laohu8.com/highlight/detail?id=2557954433","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557954433?lang=zh_cn&edition=full","pubTime":"2025-08-08 17:00","pubTimestamp":1754643617,"startTime":"0","endTime":"0","summary":"智通财经APP讯，安科生物(300009.SZ)公告，公司参股公司博生吉医药科技(苏州)有限公司(简称“博生吉医药”)、博生吉安科细胞技术有限公司(简称“博生吉安科”)自主研发的PA3-17注射液被国家药品监督管理局药品审评中心(CDE)纳入拟突破性治疗品种公示名单，公示期7日。PA3-17注射液是博生吉安科自主研发的全球首款获得新药临床试验批准的靶向CD7的自体CAR-T细胞治疗产品，用于治疗成人复发/难治性T淋巴母细胞白血病/淋巴瘤(R/RT-ALL/LBL)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1327351.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"安科生物(300009.SZ)：PA3-17注射液纳入拟突破性治疗品种","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300009","BK0070","BK0239","BK0060","BK0042"],"gpt_icon":0},{"id":"2557959515","title":"单抗概念盘中跳水，安科生物跌0.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557959515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557959515?lang=zh_cn&edition=full","pubTime":"2025-08-08 09:42","pubTimestamp":1754617371,"startTime":"0","endTime":"0","summary":"08月08日，单抗概念盘中跳水，截至09点42分，单抗概念整体指数下跌1.03%，报2658.190点。从个股上来看，该概念的成分股中，安科生物跌0.46%，华海药业、桂林三金、海正药业跌幅居前。从资金上来看，截止发稿，单抗概念概念主力净流入为-1.79亿，其中誉衡药业受到资金热捧，主力净流入2066.23万；拉长时间线来看，该板块近20日主力资金净流入-71.59亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080809425194d6afd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080809425194d6afd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0201","BK0028","600267","BK0239","300009","600521","BK0070","BK0188","BK0012","BK0042","BK0060","BK0185"],"gpt_icon":0},{"id":"2557436353","title":"安科生物：子公司鑫华坤负责化妆品护肤品业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2557436353","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557436353?lang=zh_cn&edition=full","pubTime":"2025-08-05 15:15","pubTimestamp":1754378115,"startTime":"0","endTime":"0","summary":"证券之星消息，安科生物(300009)08月05日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司是否研发生产美容护肤产品，目前该板块业务营收占比多少。安科生物回复：您好，公司子公司鑫华坤公司负责化妆品、护肤品的相关业务。谢谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080500020186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","300009","BK0239","BK0042","BK0060"],"gpt_icon":0},{"id":"2556801071","title":"8月4日安科生物现1笔折价10.87%的大宗交易 合计成交840万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556801071","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556801071?lang=zh_cn&edition=full","pubTime":"2025-08-04 16:58","pubTimestamp":1754297894,"startTime":"0","endTime":"0","summary":"证券之星消息，8月4日安科生物发生大宗交易，交易数据如下：大宗交易成交价格10.5元，相对当日收盘价折价10.87%，成交80万股，成交金额840万元，买方营业部为中国中金财富证券有限公司海南分公司，卖方营业部为中国中金财富证券有限公司海南分公司。近三个月该股共发生1笔大宗交易，合计成交8000.0手，折价成交1笔。截至2025年8月4日收盘，安科生物报收于11.78元，下跌1.01%，换手率15.8%，成交量193.04万手，成交额22.12亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080400022520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300009","BK0070","BK0042","BK0239","BK0060"],"gpt_icon":0},{"id":"2555188852","title":"7月31日安科生物（300009）龙虎榜数据：机构净卖出3286.5万元，北向资金净买入5693.86万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555188852","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555188852?lang=zh_cn&edition=full","pubTime":"2025-07-31 17:13","pubTimestamp":1753953224,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年7月31日公布的交易公开信息显示，安科生物因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年7月31日收盘，安科生物报收于12.11元，上涨20.02%，涨停，换手率27.06%，成交量330.56万手，成交额38.34亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出3286.5万元，北向资金合计净买入5693.86万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025073100027381.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0042","BK0060","300009","BK0239"],"gpt_icon":0},{"id":"2555007371","title":"7月31日安科生物涨20.02%，富国优化增强债券A/B基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2555007371","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555007371?lang=zh_cn&edition=full","pubTime":"2025-07-31 16:18","pubTimestamp":1753949892,"startTime":"0","endTime":"0","summary":"证券之星消息，7月31日安科生物涨20.02%创60日新高，收盘报12.11元，换手率27.06%，成交量330.56万手，成交额38.34亿元。重仓安科生物的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家；过去90天内机构目标均价为10.08。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为富国基金的富国优化增强债券A/B。该公募基金现任基金经理为刘兴旺。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025073100025266.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0042","BK0239","300009","BK0060"],"gpt_icon":0},{"id":"2555907220","title":"生物制品行业盘中拉升，安科生物涨18.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555907220","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555907220?lang=zh_cn&edition=full","pubTime":"2025-07-31 11:13","pubTimestamp":1753931593,"startTime":"0","endTime":"0","summary":"07月31日，生物制品行业盘中拉升，截至11点13分，生物制品行业整体指数上涨2.01%，报7031.700点。从个股上来看，该行业的成分股中，安科生物涨18.14%，特宝生物、奥浦迈等5只股涨幅超过5%。从资金上来看，截止发稿，生物制品行业主力净流入为-3.21亿，其中安科生物受到资金热捧，主力净流入4083.49万；拉长时间线来看，该板块近20日主力资金净流入-20.22亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073111131394c52d60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073111131394c52d60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0060","300009","688278","BK0216","BK0070","BK0042","688293"],"gpt_icon":0},{"id":"2555079381","title":"A股创新药概念股继续上涨 奇正藏药、汉商集团封涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2555079381","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555079381?lang=zh_cn&edition=full","pubTime":"2025-07-31 09:41","pubTimestamp":1753926064,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["300158","300683","BK0042","688189","BK1574","688278","603567","600774","BK1161","159992","BK0186","300871","BK0028","159982","BK0060","002287","06978","BK0209","BK0033","300009","BK0070","399300","BK0239","BK0188"],"gpt_icon":0},{"id":"2555732079","title":"细胞免疫治疗概念盘中拉升，安科生物涨8.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555732079","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555732079?lang=zh_cn&edition=full","pubTime":"2025-07-31 09:37","pubTimestamp":1753925823,"startTime":"0","endTime":"0","summary":"07月31日，细胞免疫治疗概念盘中拉升，截至09点37分，细胞免疫治疗概念整体指数上涨0.72%，报1038.650点。从个股上来看，该概念的成分股中，安科生物涨8.82%，翰宇药业、和元生物、华海药业涨幅居前。从资金上来看，截止发稿，细胞免疫治疗概念主力净流入为6233.06万，其中安科生物受到资金热捧，主力净流入4300.67万；拉长时间线来看，该板块近20日主力资金净流入-35.26亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507310937049728ec66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507310937049728ec66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688238","BK0060","BK0070","300009","BK0042","BK0216"],"gpt_icon":0},{"id":"2555079297","title":"单抗概念盘中拉升，安科生物涨8.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555079297","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555079297?lang=zh_cn&edition=full","pubTime":"2025-07-31 09:35","pubTimestamp":1753925746,"startTime":"0","endTime":"0","summary":"07月31日，单抗概念盘中拉升，截至09点35分，单抗概念整体指数上涨0.52%，报2743.090点。从个股上来看，该概念的成分股中，安科生物涨8.62%，舒泰神、华海药业、迈威生物-U涨幅居前。从资金上来看，截止发稿，单抗概念概念主力净流入为-4545.72万，其中安科生物受到资金热捧，主力净流入4006.64万；拉长时间线来看，该板块近20日主力资金净流入-6.60亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731093546a6ca8809&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731093546a6ca8809&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688062","300009","BK0070","BK0042","BK0060"],"gpt_icon":0},{"id":"2555016508","title":"7月30日安科生物涨5.65%，富国优化增强债券A/B基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2555016508","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555016508?lang=zh_cn&edition=full","pubTime":"2025-07-30 16:14","pubTimestamp":1753863285,"startTime":"0","endTime":"0","summary":"证券之星消息，7月30日安科生物涨5.65%创60日新高，收盘报10.09元，换手率10.16%，成交量124.08万手，成交额12.38亿元。重仓安科生物的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家；过去90天内机构目标均价为10.08。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为富国基金的富国优化增强债券A/B。该公募基金现任基金经理为刘兴旺。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025073000025258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0042","300009","BK0060","BK0239"],"gpt_icon":0},{"id":"2553828205","title":"安科生物：与宝济药业关于SJ02的合作合法有效","url":"https://stock-news.laohu8.com/highlight/detail?id=2553828205","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553828205?lang=zh_cn&edition=full","pubTime":"2025-07-24 17:30","pubTimestamp":1753349432,"startTime":"0","endTime":"0","summary":"证券之星消息，安科生物(300009)07月24日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司7月9日披露与宝济生物就SJ02达成独家代理，但是24年宝济已经授权欧加隆商业化权益，请问以上合作是否有冲突？安科生物回复：您好，宝济药业与欧加隆公司关于“SJ02”的相关授权协议已经解除，欧加隆公司已经对此事进行了公告，安科生物与宝济药业关于“SJ02”的合作合法有效，谢谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072400027538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300009","BK0070","BK0060","BK0239","BK0042"],"gpt_icon":0},{"id":"2551137423","title":"维升药业-B(02561)携手安科生物 加速长效生长激素中国商业化进程","url":"https://stock-news.laohu8.com/highlight/detail?id=2551137423","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551137423?lang=zh_cn&edition=full","pubTime":"2025-07-15 10:19","pubTimestamp":1752545983,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，维升药业-B7月14日宣布与安科生物签订战略合作框架协议。在合作期限内，维升药业授权安科生物在中国境内特定区域内排他性独家推广隆培促生长素产品。维升药业与安科生物成功牵手，双方围绕隆培促生长素展开的业务也有望完善安科生物在生长激素方面的布局，实现全剂型覆盖，凭借维升药业创新助力冲击中国市场。该产品目前已在美国及欧洲获批上市，预计2025年内在中国获批，计划在2028年将实现本地化商业生产。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1317772.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300009","BK0070","BK0239","02561","BK0060","BK1161","BK0042"],"gpt_icon":0},{"id":"2550166044","title":"细胞免疫治疗概念盘中拉升，安科生物涨4.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550166044","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550166044?lang=zh_cn&edition=full","pubTime":"2025-07-10 09:46","pubTimestamp":1752111977,"startTime":"0","endTime":"0","summary":"07月10日，细胞免疫治疗概念盘中拉升，截至09点46分，细胞免疫治疗概念整体指数上涨0.53%，报937.880点。从个股上来看，该概念的成分股中，安科生物涨4.45%，康泰生物、ST香雪、复星医药涨幅居前。从资金上来看，截止发稿，细胞免疫治疗概念主力净流入为-2.17亿，其中安科生物受到资金热捧，主力净流入2987.07万；拉长时间线来看，该板块近20日主力资金净流入-50.31亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710094617953cd5cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710094617953cd5cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0096","BK0042","300009","BK0188","BK0239","BK0012","BK0060","600196","BK0196","BK0070","BK0183","BK0187","BK0175","BK0028"],"gpt_icon":0},{"id":"2550682899","title":"安科生物(300009.SZ)及子公司将独家代理重组人卵泡刺激素-CTP 融合蛋白注射液","url":"https://stock-news.laohu8.com/highlight/detail?id=2550682899","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550682899?lang=zh_cn&edition=full","pubTime":"2025-07-09 16:48","pubTimestamp":1752050882,"startTime":"0","endTime":"0","summary":"公告显示，重组人卵泡刺激素-CTP融合蛋白注射液是一种长效重组人卵泡刺激素，联合促性腺激素释放激素拮抗剂用于控制性卵巢刺激，晟济药业于2023年12月向国家药品监督管理局递交SJ02药品注册上市申请，有望成为国内首款获批上市的长效FSH-CTP。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1315709.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0070","300009","BK0042","BK0060","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1755154333188,"stockEarnings":[{"period":"1week","weight":0.0721},{"period":"1month","weight":0.3109},{"period":"3month","weight":0.3939},{"period":"6month","weight":0.3458},{"period":"1year","weight":0.4078},{"period":"ytd","weight":0.4175}],"compareEarnings":[{"period":"1week","weight":0.0136},{"period":"1month","weight":0.0465},{"period":"3month","weight":0.0895},{"period":"6month","weight":0.1006},{"period":"1year","weight":0.2844},{"period":"ytd","weight":0.099}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"安徽安科生物工程(集团)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"67145人(较上一季度减少1.44%)","perCapita":"18194股","listingDate":"2009-10-30","address":"安徽省合肥市蜀山区长江西路669号高新区海关路K-1","registeredCapital":"167252万元","survey":"　　安徽安科生物工程(集团)股份有限公司的主营业务是基因工程药品、生物检测试剂的研发、生产、销售。公司的主要产品是人干扰素α2b注射液、注射用人干扰素α2b、人干扰素α2b栓剂、人干扰素α2b乳膏、人干扰素α2b滴眼液、注射用人生长激素、人生长激素注射液、注射用曲妥珠单抗、活血止痛膏、麝香镇痛膏、麝香壮骨膏、舒筋活络止痛膏、狗皮膏。公司入选2022年度江苏省专精特新中小企业、2022年获得江苏省省级企业技术中心认定。","listedPrice":17},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.7","shortVersion":"4.34.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安科生物(300009)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安科生物(300009)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安科生物,300009,安科生物股票,安科生物股票老虎,安科生物股票老虎国际,安科生物行情,安科生物股票行情,安科生物股价,安科生物股市,安科生物股票价格,安科生物股票交易,安科生物股票购买,安科生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安科生物(300009)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安科生物(300009)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}